Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 5, 2026
Approximately 5 minutes
Modification Procedure for Pharmaceutical Laboratory Authorizations by AEMPS in Spain
Modification Procedure for Pharmaceutical Laboratory Authorizations by AEMPS in Spain
1. Overview and Requirement for Prior Authorization
Any modification to the conditions established in the authorization of a pharmaceutical laboratory (as manufacturer and/or importer) requires prior authorization from the Spanish Agency for Medicines and Medical Devices (AEMPS). This ensures continued compliance with quality and safety standards.
AEMPS Modificación de la autorización de un laboratorio farmacéutico
2. Application Submission
Applications for modification must be submitted exclusively electronically through the LABOFAR platform at the AEMPS Electronic Headquarters.
Platform: LABOFAR
AEMPS Modificación de la autorización de un laboratorio farmacéuticos
3. Evaluation Process
AEMPS evaluates the application, which may include an on-site inspection to verify that the laboratory maintains adequate personnel and material resources to guarantee pharmaceutical quality for the requested operations.
Timelines may be suspended if additional information or clarifications are requested (with a one-month response deadline). Incomplete applications allow ten days for rectification, or the request is considered withdrawn.
AEMPS Modificación de la autorización de un laboratorio farmacéutico
4. Resolution and Notification
The standard resolution notification period is 30 days from receipt of the application, exceptionally extendable to 90 days.
If the evaluation is unfavorable, AEMPS notifies the reasons, granting 15 days for allegations and additional documentation.
Upon favorable resolution, the modified authorization is issued and immediately communicated to the applicant and relevant autonomous communities.
AEMPS Modificación de la autorización de un laboratorio farmacéutico
5. Additional Notes
No specific classification of modifications (e.g., major/minor) or associated fees are detailed. For cases involving suspension or revocation (not modifications), separate procedures apply with a maximum 6-month resolution period.
AEMPS Modificación de la autorización de un laboratorio farmacéutico
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Authorization Procedure for Pharmaceutical Manufacturing Laboratories by AEMPS in Spain
AEMPS requires prior authorization for pharmaceutical laboratories manufacturing or importing medicines in Spain, including export-only facilities and importers performing control analyses, with applications submitted electronically and involving GMP-compliant facilities, qualified personnel, and inspections.
Approximately 5 minutes
Frequently Asked Questions on Pharmaceutical Laboratories Authorization and Operations by AEMPS in Spain
AEMPS addresses common queries on pharmaceutical laboratory authorization in Spain, covering importation requirements, technical director qualifications, subcontracting limits, and responsibilities under EU and national GMP standards.